MEI Pharma, Inc.
San Diego
California
United States
378 articles about MEI Pharma, Inc.
-
MEI Pharma (MEIP) (Formerly known as Marshall Edwards, Inc.) CEO To Present at Wedbush Life Sciences Management Access Conference
8/1/2013
-
MEI Pharma (MEIP) (Formerly known as Marshall Edwards, Inc.) Initiates Phase II Clinical Trial of Pracinostat and Vidaza® in Frontline Myelodysplastic Syndrome
6/18/2013
-
MEI Pharma (MEIP) (Formerly known as Marshall Edwards, Inc.) Adds Former YM BioSciences CEO Nick Glover to Board of Directors
6/11/2013
-
MEI Pharma (MEIP) (Formerly known as Marshall Edwards, Inc.) CEO to Present at Jefferies and Co. Global Healthcare Conference
5/29/2013
-
MEI Pharma (MEIP) (Formerly known as Marshall Edwards, Inc.) CEO To Present at Needham Healthcare Conference
4/23/2013
-
MEI Pharma (MEIP) (Formerly known as Marshall Edwards, Inc.)'s Mitochondrial Inhibitor Drug Candidate ME-344 Delays Tumor Growth in Recurrent Ovarian Cancer Model
4/11/2013
-
MEI Pharma (MEIP) (Formerly known as Marshall Edwards, Inc.) Announces $15.2 Million Registered Offering of Common Stock
4/5/2013
-
MEI Pharma (MEIP) (Formerly known as Marshall Edwards, Inc.) to Host Annual Meeting of Stockholders
3/21/2013
-
MEI Pharma (MEIP) (Formerly known as Marshall Edwards, Inc.) CEO to Present at ROTH Conference
3/12/2013
-
MEI Pharma (MEIP) (Formerly known as Marshall Edwards, Inc.) to Present at Cowen and Company Health Care Conference
2/27/2013
-
MEI Pharma (MEIP) (Formerly known as Marshall Edwards, Inc.) Adds Cancer Drug Development Veteran Tom Reynolds to Board of Directors
2/11/2013
-
MEI Pharma (MEIP) (Formerly known as Marshall Edwards, Inc.) Announces Retirement of Chairman Bryan Williams From Board of Directors and Appointment of Christine White as Lead Director
1/30/2013
-
MEI Pharma (MEIP) (Formerly known as Marshall Edwards, Inc.) Announces Closing of $27.5 Million Private Placement
12/19/2012
-
MEI Pharma (MEIP) (Formerly known as Marshall Edwards, Inc.)'s Mitochondrial Inhibitor Drug Candidate ME-344 Named One of Top 10 Oncology Products for 2012
11/19/2012
-
MEI Pharma (MEIP) (Formerly known as Marshall Edwards, Inc.) Reports New Data Showing High Response Rates in Clinical Trial of Pracinostat and Azacitidine in Myelodysplastic Syndrome
11/6/2012
-
MEI Pharma (MEIP) (Formerly known as Marshall Edwards, Inc.) Issued European Patent for Lead Mitochondrial Inhibitor Drug Candidate ME-344
10/2/2012
-
MEI Pharma (MEIP) (Formerly known as Marshall Edwards, Inc.) CEO to Present at Stifel Nicolaus Healthcare Conference
8/29/2012
-
S*Bio of Singapore Sells Cancer Drug Rights to MEI Pharma (MEIP) (Formerly known as Marshall Edwards, Inc.) for $75 Million
8/10/2012
-
MEI Pharma (MEIP) (Formerly known as Marshall Edwards, Inc.) to Acquire Pracinostat for Up to $75.2 Million
8/8/2012
-
Novogen Limited Announces Merger Agreement With Kai Medical and Distribution of MEI Pharma (MEIP) (Formerly known as Marshall Edwards, Inc.) Shares
7/27/2012